Jingguang Chen, President of the North American Catalysis Society, has announced that Enrique Iglesia, Theodore Vermeulen Professor in Chemical Engineering at the University of California, Berkeley has been named the recipient of the 2021 NACS Award for Distinguished Service in the Advancement of Catalysis.
The College of Chemistry is pleased announce that Professor Jeffrey Long has received a 2020 award from the Royal Society of Chemistry. The Society annualy recognizes leaders in various fields of chemistry around the world. This year, the Society acknowledged over 80 individuals and teams for their exceptional achievements in advancing the chemical sciences through their work in everything from education and research, to innovation, policy and volunteering.
Markita Landry and UC Berkeley recently filed patents on a new nanotube technology to delete genes in crop plants without the risk of inserting new genes. Editing the genome of crop plants can boost such traits as disease resistance or drought tolerance. Since the new process adds no genes to the plant genome in the editing process, it conforms to non-GMO requirements in the U.S. and several other countries outside Europe.
The Molecular Sciences Software Institute has launched an open-source website that will allow biomolecular scientists from around the world to share computer-aided drug-testing simulations targeting the protein at the center of COVID-19. Under the leadership of Teresa Head-Gordon, the MolSSI team started work on the COVID-19 website about a month ago, after scores of scientists began discussing ways to share simulation modeling data they had on the coronavirus.
The College of Chemistry at UC Berkeley is pleased to announce that the Department of Chemical and Biomolecular Engineering (CBE) has been ranked number two in a tie with Caltech in the 2021 U.S. News and World Report list of best chemical engineering graduate schools in the United States. MIT was in first place.
With the help of photolithography and a creative use of programmable DNA, UC Berkeley researchers have created a new technique that can rapidly “print” two-dimensional arrays of cells and proteins that mimic a wide variety of cellular environments in the body — be it the brain tissue surrounding a neural stem cell, the lining of the intestine or liver or the cellular configuration inside a tumor. This technique could help scientists develop a better understanding of the complex cell-to-cell messaging that dictates a cell’s final fate.
Guided by CRISPR pioneer Jennifer Doudna, a formidable entrepreneur in her own right, C&EN profiled 15 women working in the Chemical industry in academics and startups in C&EN's 2020 Trailblazers. Four of them are affiliated with UC Berkeley's College of Chemistry. They have collectively launched more than 30 start-ups aimed at developing treatments for rare diseases, building better batteries, and more. They’re chemical scientists at the top of their game. They’re role models building and mentoring teams. And yes, they’re badasses. They live by the motto “Nobody ever got anywhere by listening to no.”
Jay Keasling, Professor, Department of Chemical & Biomolecular Engineering and JBEI’s Chief Executive Officer, was featured in NHK World’s interview program “Direct Talk”. Keasling, a pioneer of synthetic biology, talks about the impact that this interdisciplinary technology can have in people’s lives as well as addresses its safety concerns.
This year, there will be three new lab groups forming under three new professors. Alanna Schepartz and Michael Zuerch are joining the Department of Chemistry; Karthik Shekhar will be in the Department of Chemical and Biomolecular Engineering. In the fall, new professors are often still in the process of moving in and awaiting new lab space setups.
The University of California has received two new patents for use of the revolutionary CRISPR-Cas9 technology, increasing its gene-editing patent portfolio to 10. Five more are expected to be issued by the U.S. Patent and Trademark Office by the end of the summer.
The patents were awarded today to UC and its co-patentees, the University of Vienna and Emmanuelle Charpentier, who co-invented CRISPR-Cas9 with UC Berkeley's Jennifer Doudna.